DJO Expects Improved Growth in 2020 Second Half

DJO's logo

DJO reported orthopedic revenue of USD $85.2 million, -33.8% vs. 2Q19. The company’s joint replacement business faced sharp declines in April, but improved sequentially throughout the quarter to exit June with sales down only -3%. July brought a return to growth, and company leadership expects 3Q to be roughly flat for its overall MedTech...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us